Home > HP (current issue) > Comment | Search

Return to PJ Online Home Page

Hospital Pharmacist
Vol 10 No 9 p370
October 2003

Hospital Pharmacist back issues

Comment

Vision for the future – focusing on hospital pharmacy

By Alison B. Ewing, MSc, MRPharmS

Miss Ewing is clinical director of pharmacy, the Royal Liverpool and Broadgreen University Hospital NHS Trust and Vice-President of the Royal Pharmaceutical Society

For decades, to work in hospital as a pharmacist was to work in the twilight zone of the profession. No one really knew what went on in the basement departments, except that copious amounts of disinfectant solutions and various rather smelly ointments were produced. There were few rules or regulations and clinical pharmacy services were only a vague dream. How different things are today!

Modern departments with high-tech systems for aseptic production and dispensing are springing up all over the country. And it would seem that at last there has been a rising wave of interest in hospital pharmacy from the powers that be – both those inside and outside the NHS. In September 2000, the Government published “ Pharmacy in the future – implementing the NHS plan”. Since then, in December 2001 we have had the Audit Commission’s “A spoonful of sugar”, which compared standards across England and Wales.

Now we have “A vision for pharmacy in the new NHS for England”, issued by the Department of Health in July. Perhaps the politicians and civil servants have, at long last, realised the importance of the high quality medicines management systems in place in hospitals and what can be learned from this by other sectors!

As well as implying that hospital pharmacy has moved up the Government’s agenda, the “vision document” has some other useful messages. For example, the management of pharmacy services features strongly in the vision document, and the support for the progress made to date is reassuring. The crucial point on management set out in the vision document is that chief pharmacists (or should I say clinical directors of pharmacy) are recognised as having a vital role to play at senior management level within trusts. Every single person in this position must now push for this wider role, if it has not already been established in their trust. Those trust chief executives who choose to ignore such moves do so at their peril, because the next round of the medicines management framework will expect this to have happened and the benefits to have been realised.

There is also a welcome emphasis on working across the boundaries of primary and secondary care, which is to set the baseline for the future development of pharmaceutical services to the population of each health economy. This will enable easier implementation of other Government initiatives such as the national service frameworks. We already have some joint appointments across both sectors for chief pharmacist positions and I am sure that we will see many more.

There is no doubt that the rational use of antibiotics advocated in the vision document is essential for the future health benefits of the nation. The £12 million that has been made available for promoting this is most welcome. However, in reality that figure means around £13 to £18,000 per trust per annum – not enough for a full time post at the desirable grade! Even so, the focus on this issue emphasises the rising importance of the appropriate use of medicines in the Government’s view. We need to ensure that we use the money wisely and achieve the stated aims.

There is also great emphasis on the expanded use of new technology in hospital pharmacy. Having just implemented a robot system for dispensing, I know the difficulties involved in securing funding and working with the currently under-resourced NHS IT departments. The expansion of the NHSnet to community pharmacy will be of major benefit for the transfer of important information outside the hospital to improve patient care. Unfortunately, the vision document does not indicate what funding will be avilable for this, or for all hospital pharmacy departments to modernise.

On the other hand, it does indicate that substantial funding will be accessible for manufacturing within hospitals. This is welcomed, as we all know how difficult it can be to obtain from the pharmaceutical industry products that are essential for patient care but commercially unattractive.

The focus on achieving an appropriate skill mix is also welcome. Hospitals have for many years pushed back the barriers for novel staffing systems to be introduced. Indeed “technician checking” grew out of the necessity to expand clinical pharmacist roles in hospitals. This principle is accepted in the vision document, which takes the issue further, expanding it outside hospitals into community pharmacy, reviewing the supervision requirements that currently exist. The registration of all pharmacy technicians, a principle recognised in the vision document, will provide a common set of standards for those working in all sectors. However, the lead will most certainly come from secondary care organisations. Expansion and development of the technical workforce is vital for continuous improvement in the quality of patient care.

“Agenda for change” is upon us and if we believe the vision document, the situation will be that by “…. changing traditional ways of working ….” we will reward staff and encourage them to stay in the NHS and improve patient care. Doctors and dentists have been allowed to opt out of this programme, but pharmacy is still included.
I will wait and see with great interest what happens at the early implementation sites!

There is no doubt that consultant pharmacists with supplementary or independent prescribing rights will be of benefit to patient care. Indeed in many cases, introducing these powers will be formalising systems that already exist. The recognition of this in the vision document will give power to chief pharmacists to press for funding for these posts.

The principles set out in the vision document are broadly welcome. Some of the detail is lacking, but I guess we will have to wait for the consultations to end to see whether these gaps will be filled. I believe that with the next round of the “Hospital medicines management framework” we will see medicines management as a top priority for trust boards.

Clinical directors of pharmacy (or chief pharmacists as they used to be known!) will need to make sure that they are ready to rise to the challenge.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal